I am a Senior Scientist at Chromocell Biopharma and guest Investigator in the Laboratory of RNA Molecular Biology, Rockefeller University, NY. Formerly, I was Executive Director, R&D, Reproductive Health (RH), and Senior Scientist (Professor), Population Council. I am an Associate Editor and Series Editor for a collection of expert reviews on Women’s Sexual and Reproductive Health in FASEB Journal.
My background is in Pharmacology and Physiology, with my doctorate from the New York University Graduate School of Medical Sciences, and the Abby Mauze Rockefeller postdoctoral fellowship in Endocrinology, Cornell University Medical College. Following my first appointment as an Assistant Professor of Pharmacology, Fairleigh Dickinson School of Dentistry, I have spent my scientific research career as the Principal Investigator and Head of the Laboratory of Mechanisms in Reproductive Health (RH), Population Council. I served as Co-Director for two NICHD P50/U54 Specialized Centers in male infertility and female contraception, respectively. My R&D program in male and female reproduction received continuous independent NIH funding for 30+ years.
My research focuses on understanding molecular regulatory mechanisms in (in)fertility, contraceptive development, sexual and reproductive health. My translational research seeks to understand signaling mechanisms underlying transcriptional and translational control of spermatogenesis, growth factor and cytokine paracrine regulation of germ cell development, and testicular and oocyte modifications mediated by tyrosine kinases, JAK-STAT and SUMO pathways.
I have been honored to serve as both the Council’s Director of RH Fellowship Programs and as a long-standing mentor for clinical and basic postdoctoral and early career researchers, including physician-scientists, biomedical and veterinary fellows. Together with an expert lab and core facility staff, several dozens of undergraduates from historically underrepresented communities and fellows from developing countries were mentored and provided with a reproductive research training.
I have a long record of service to SSR and reproductive community writ large. I am a career-long SSR member, participating in annual meetings, including on several trainee panels and twice as Chair of the Public Affairs Committee (PAC) and a member (2010-present). From 2010-19, I represented SSR on the Board of Directors for the Federation of American Societies for Experimental Biology (FASEB). Continuing this service, I’ve been elected to several FASEB’s leadership positions: Executive, DEI, and PAC Committees, and as VP-Science Policy and President.
As SSR’s rep, I have been proactive on FASEB’s initiatives for its 28-member scientific societies in Diversity, Equity, Accessibility, and Inclusion as well as leading a new One Health initiative. I recently convened two virtual conferences on climate change, water and soil quality and health, and a panel with bio-geoscientists on EDCs and ecosystem health.
In service to the community, I served as a consultant with Gates Foundation and WHO to landscape priorities to advance innovations in family planning. I served as a member of two standing NIH scientific review panels, including Chair, Reproduction, Andrology and Gynecology and as Chair on several NIH panels for Specialized Centers of Reproduction. My peer review service includes 120+ panels.
I am a senior scientific advisor to a non-profit developing an innovative cure for AIDs.